Table 4: NF-kB levels (ng/μg of protein) in nuclear extracts of LPS stimulated PBMCs in various co-infected subgroups of HIV-1 positive donors.
NF-kB levels (ng/µg of protein) |
Subgroups of various co-infections in HIV-1 +ve donors |
|||||||||
HPgV +ve (n = 60) |
TTV +ve (n = 48) |
HPgV -ve/TTV -ve (n = 54) |
||||||||
Rep (n = 38) |
Vol (n = 22) |
Rep (n = 16) |
Vol (n = 32) |
Rep (n = 19) |
Vol (n = 35) |
|||||
HPgV viremia on follow up |
||||||||||
Total Rep |
Neg (n = 24) |
Pos (n = 14) |
||||||||
En |
Mean SD |
12.1 8.1 |
20.4 6.5a |
6.9 2.6 |
0.3 0.3b |
10.3 4.2 |
2.4 1.2 |
9.7 3.1 |
2.1 0.8 |
|
Fu |
Mean SD |
6.9 6.4 |
13.9 4.9a |
2.7 1.8 |
0.7 0.4b |
5.3 2.3 |
4.9 2.1 |
5.1 2.1 |
2.6 1.9 |
Statistical comparisons: a: Significantly higher values, vs. Pos (p < 0.001) at enrollment (En) as well as on follow up (Fu); b: Significantly lower value in Vol category of donors in HPgV +ve subgroup vs. similar category of donors in other two subgroups (p < 0.001) at enrollment (En) as well as on follow up (Fu)
Note: The mean ± SD level of NF-kB (ng/µg of protein) in non-donor controls (n = 50) was 0.48 ± 0.08.